Kwong DL, Sham JS, Au GK, Chua DT, Kwong PW, Cheng AC
Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol
Liu MT, Hsieh CY, Chang TH, Lin JP, Huang CC, Wang AY.
Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol
Ponta H, Sherman I, Herrlich PA.
CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol
Goodison S, Urquidi V, Tarin D.
CD44 cell adhesion molecules. Mol Pathol
Kalish ED, Iida N, Moffat FL, Bourguignon LY.
A new CD44V3-containing isoform is involved in tumor cell growth and migration during human breast carcinoma progression. Front Biosci
Iida N, Bourguignon LY.
New CD44 splice variants associated with human breast cancers. J Cell Physiol
Ni HM, Leong AF, Cheong D, Hooi SC.
Expression of CD44 variants in colorectal carcinoma quantified by real-time reverse transcriptase-polymerase chain reaction. J Lab Clin Med
Kuhn S, Koch M, Nübel T, Ladwein M, Antolovic D, Klingbeil P
A complex of EpCAM, claudin-7, CD44 variant isoforms, and tetraspanins promotes colorectal cancer progression. Mol Cancer Res
Lee SC, Harn HJ, Lin TS, Yeh KT, Liu YC, Tsai CS
Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms. Ann Thorac Surg
Handorean AM, Yang K, Robbins EW, Flaig TW, Iczkowski KA.
Silibinin suppresses CD44 expression in prostate cancer cells. Am J Transl Res
Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY.
CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope
Kunishi M, Kayada Y, Yoshiga K.
Down-regulated expression of CD44 variant 6 in oral squamous cell carcinoma and its relationship to regional lymph node metastasis. Int J Oral Maxillofac Surg
Tsuruoka S, Matsuo K, Ishikawa A, Yamamoto N, Yamashita Y, Takahashi T.
Prognostic significance of CD44v3 and CD44v6 in oral squamous cell carcinoma of the tongue. Oral Med Pathol
Uwa N, Kataoka TR, Torii I, Sato A, Nishigami T, Song M
CD44 expression is related to poor prognosis of hypopharyngeal squamous cell carcinoma. Acta Otolaryngol
R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing
Sobin LH, Gospodarowicz MK, Wittekind C.
TNM Classification of Malignant Tumours. Hoboken, NJ: Wiley-Blackwell, 2009
Bourguignon LY, Gilad E, Brightman A, Diedrich F, Singleton P.
Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem
Wang SJ, Bourguignon LY.
Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg
Trachootham D, Alexandre J, Huang P.
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Nat Rev Drug Discov
Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN
Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature
Gottesman MM, Fojo T, Bates SE.
Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer
Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A